Navigation Links
An Increase in the Diagnosed Prevalent Population Will Drive Growth of Nearly $4.3 Billion in the Chronic Obstructive Pulmonary Disease Market
Date:6/23/2009

Emerging Combination Products from GlaxoSmithKline/Theravance, Boehringer Ingelheim and Novartis Will Drive Growth, According to a New Report from Decision Resources

WALTHAM, Mass., June 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a 28 percent increase in the diagnosed prevalent population will drive growth in the chronic obstructive pulmonary disease (COPD) drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Despite market constraints that include currently low diagnosis rates, pricing and reimbursement restrictions and challenging regulatory landscapes, the COPD drug market will grow by nearly $4.3 billion from 2008 to 2018.

The new Pharmacor report entitled Chronic Obstructive Pulmonary Disease finds that maintenance therapies dominated the COPD market in 2008 as nearly 80 percent of COPD sales were generated by such agents. Although safety concerns are associated with several maintenance therapies commonly prescribed for COPD, including ICS-containing products as well as inhaled anticholinergics, physicians indicate that they will continue to widely prescribe these drugs to their COPD patients but will remain vigilant in monitoring the safety of these drugs in their patients who receive them. The report finds that as new long-acting beta2 agonist (LABA)/inhaled corticosteroid (ICS) combinations, long-acting muscarinic antagonists (LAMAs), and LABA/LAMA products emerge from clinical development over the next decade, the use of maintenance therapies will continue to increase.

Several once-daily dosed LABAs such as Novartis's indacaterol, Boehringer Ingelheim's BI-1744-CL and GlaxoSmithKline/Theravance's GW-642444 will also enter the COPD market over the next decade. The report finds that these emerging once-daily LABAs will be the cornerstones of combination product development programs which will result in new LABA/ICSs and LABA/LAMAs, the latter being a new and promising class of combination drugs. While all of these agents will achieve their greatest potential as components of combination products, drug marketers are expected to position these agents as add-on therapy to LAMA treatment and/or as monotherapies for first-line use in patients with moderate COPD in order to maximize the commercial potential of these molecules.

"While Advair and Spiriva dominated the COPD market in 2008, we expect their share of the COPD market to decrease through 2018," said Decision Resources Analyst Regina Jammen, M.Sc. "As new maintenance therapies and non-innovator versions of several market-leading branded products launch, the COPD market will shift from a few key products to numerous therapies with subsequently less market concentration on only a few brands. However, even with these changes to the market landscape, the unmet need remains for drugs that can dramatically reduce exacerbation rates and/or slow or halt the progression of COPD."

About Decision Resources

Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Decision Resources                      Decision Resources, Inc.
    Christopher Comfort                     Elizabeth Marshall
    781-296-2597                            781-296-2563
    ccomfort@dresources.com                 emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. U.S. Army Increases Medical and Dental School Benefits
2. A 50% Increase in Medical Bankruptcies - A Worry for Adults Assisting Aging Parents
3. Winner Medical to Benefit From the Increase of Tax Rebate Rate for Exports From China
4. Hodgkin lymphoma survivors have increased risk of stroke and transient ischemic attack
5. No Matter the Vehicle, Sending Text Messages While Driving Increases Risk of Accidents, Warns New York Auto Accident Lawyer
6. Hartford grants increase support for geriatric social work training
7. Study Shows Increases in Working After 65 and Using Commercial Insurance
8. Depression may increase Alzheimers risk in people with memory problems
9. Despite Generic Erosion of Key Brands, the Hospital-Acquired Gram Negative Infections Drug Market Will Increase by $1 Billion from 2008 to 2018
10. Colonoscopy Risks Increase With Age and Illness
11. For Men Over 50, Odds of Eye Discomfort Increases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in property taxes a year. In some states—like New York, New Jersey, Massachusetts, ... contrast, many overseas retirement havens have extremely low property-tax rates, which contributes to ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... ORANGE COUNTY, Calif. , Oct. 10, 2017  NDS received ... Mobile  — a medical-grade battery-powered display stand specifically designed for ... aims to transform technology into a clinical solution to support the ... costs. Innovative Design ... NDS ZeroWire Mobile Wireless Solution ...
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
Breaking Medicine Technology: